Humana (HUM) Reaffirms FY16 Guidance Ahead of Investor Meetings
- Wall St. falls as earnings from some big names disappoint
- General Motors (GM) Tops Q3 EPS by 28c
- Procter & Gamble (PG) Tops Q1 EPS by 5c
- DuPont (DD) Tops Q3 EPS by 14c; Boosts FY16 EPS Outlook; Says Continuing to Work with Regulators
- Pre-Open Stock Movers 10/25: (SAEX) (CWEI) (SWFT) Higher; (DPRX) (CRBP) (UA) Lower (more...)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Humana (NYSE: HUM) disclosed the following on Tuesday:
Item 7.01 Regulation FD Disclosure
Members of Humana Inc.’s senior management team are scheduled to meet with investors at various times between September 6, 2016 and the end of the month. During such meetings, Humana’s management expects to reaffirm its earnings per share (EPS) guidance for the year ending December 31, 2016 as follows:
Generally Accepted Accounting Principles (GAAP)
At least $8.55
Transaction and integration costs (a)
At least 0.37
Amortization of identifiable intangibles (a)
Adjusted (non-GAAP) guidance (a)
At least $9.25
This guidance is consistent with that issued in Humana’s current report on Form 8-K filed with the U.S. Securities and Exchange Commission on August 3, 2016.
The company has included Adjusted EPS guidance in this Form 8-K, which is a financial measure that is not in accordance with GAAP. Management believes that Adjusted EPS, when presented in conjunction with GAAP EPS, is useful to both management and its investors in analyzing the company’s ongoing business and operating performance. Consequently, management uses Adjusted EPS as an indicator of business performance, as well as for operational planning and decision making purposes. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. Adjusted EPS guidance for FY16 excludes pretax transaction and integration costs associated with the pending transaction with Aetna Inc. of $61 million, or $0.37 per diluted common share, as well as $78 million pretax, or $0.33 per diluted common share associated with the amortization expense for identifiable intangibles. Transaction and integration costs beyond those incurred in the first half of 2016 are to be determined.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Tennant Co. (TNC) Tops Q3 EPS by 6c; Updates FY16 Outlook
- Philip Morris (PM) Discloses Formal Probe Related to PM Thailand in 10-Q Filing
- Smart Sand (SND) Commences 10.6M Share IPO; Sees Pricing of $15 - $18/Share
Create E-mail Alert Related CategoriesCorporate News, Guidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!